Willem M Lijfering

Summary

Affiliation: University Medical Center Groningen
Country: The Netherlands

Publications

  1. Lijfering W, Brouwer J, Veeger N, Bank I, Coppens M, Middeldorp S, et al. Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood. 2009;113:5314-22 pubmed publisher
    ....
  2. Lijfering W, Middeldorp S, Veeger N, Hamulyak K, Prins M, Buller H, et al. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A. Circulation. 2010;121:1706-12 pubmed publisher
    ..In this study, individuals with homozygous factor V Leiden and/or homozygous prothrombin G20210A or double heterozygous carriers of factor V Leiden and prothrombin G20210A did not have a high risk of recurrent venous thrombosis. ..

Detail Information

Publications2

  1. Lijfering W, Brouwer J, Veeger N, Bank I, Coppens M, Middeldorp S, et al. Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood. 2009;113:5314-22 pubmed publisher
    ....
  2. Lijfering W, Middeldorp S, Veeger N, Hamulyak K, Prins M, Buller H, et al. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A. Circulation. 2010;121:1706-12 pubmed publisher
    ..In this study, individuals with homozygous factor V Leiden and/or homozygous prothrombin G20210A or double heterozygous carriers of factor V Leiden and prothrombin G20210A did not have a high risk of recurrent venous thrombosis. ..